T0	Participants 67 152	after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome.
T1	Participants 222 281	patients with the acquired immunodeficiency syndrome (AIDS)
T2	Participants 506 677	all participants had sterile cultures of cerebrospinal fluid, blood, and urine after following a standardized course of therapy for culture-proved cryptococcal meningitis.
T3	Participants 891 1123	Of 84 patients initially enrolled, 16 (19 percent) were found to have silent, persistent infection on the basis of cultures that became positive after entry into the study; 7 other patients were lost to follow-up shortly after entry
T4	Participants 1132 1153	remaining 61 patients
T5	Participants 2022 2040	patients with AIDS